½ÃÀ庸°í¼­
»óǰÄÚµå
1555638

°æÄ«Å×ÅÍ ´ëµ¿¸ÆÆÇ ġȯ ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)

Transcatheter Aortic Valve Replacement Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 175 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â À̹ø¿¡ ¼¼°èÀÇ °æÄ«Å×ÅÍ ´ëµ¿¸ÆÆÇ ġȯ¼ú(TAVR) ½ÃÀå¿¡ °üÇÑ Á¾ÇÕ º¸°í¼­¸¦ ¹ßÇàÇϰí, ÃËÁø¿äÀΡ¤±âȸ¡¤°úÁ¦¡¤µ¿ÇâµîÀÇ ÁÖ¿ä ½ÃÀå ¿ªÇÐÀ» »ó¼¼ÇÏ°Ô ºÐ¼®Çϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ ±¸Á¶¿Í Àü¸Á¿¡ °üÇÑ ±ÍÁßÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • °æÄ«Å×ÅÍ ´ëµ¿¸ÆÆÇ ġȯ¼ú ½ÃÀå ±Ô¸ð(2024E) : 56¾ï 4,000¸¸ ´Þ·¯
  • ¿¹Ãø ½ÃÀå°¡Ä¡(2031F) : 105¾ï ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2024-2031³â) : 6.5%

°æÄ«Å×ÅÍ ´ëµ¿¸ÆÆÇ ġȯ¼ú ½ÃÀå - Á¶»ç ¹üÀ§ :

TAVR ½ÃÀåÀº ¼Õ»óµÈ ´ëµ¿¸Æ ÆÇ¸·À» ±³Ã¼Çϱâ À§ÇÑ °æÄ«Å×ÅÍ ±â¹Ý ½Ã¼ú¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖÀ¸¸ç, ƯÈ÷ ±âÁ¸ °³½É¼ú¿¡ ´ëÇÑ °íÀ§Çè ¶Ç´Â Áߵ À§Çè ȯÀÚ¸¦ ´ë»óÀ¸·Î Çϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ÆÇ¸· ±â¼ú°ú ÃÖ¼Ò Ä§½À ±â¼úÀÇ ¹ßÀüÀ¸·Î ºü¸£°Ô ¼ºÀåÇϰí ÀÖÀ¸¸ç, °í·ÉÈ­ »çȸ¿Í ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ Àü ¼¼°è º´¿ø, ½ÉÀå Àü¹®¼¾ÅÍ ¹× Ŭ¸®´Ð¿¡¼­ TAVR ½Ã¼úÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ :

¼¼°è TAVR ½ÃÀåÀº ƯÈ÷ ÀúÀ§Çè ȯÀڵ鿡 ´ëÇÑ TAVR ½Ã¼úÀÇ ÀûÀÀÁõ È®´ë°¡ ÁÖ¿ä ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. À¯¿¬Çϰí Áøº¸µÈ Àü´Þ ½Ã½ºÅÛÀÇ °³¹ß·Î º¸´Ù ¿øÈ°ÇÏ°í ¾ÈÀüÇÑ ÀÌ½Ä ¼ö¼úÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ¹ëºê Àç·áÀÇ Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å°ú ¹ëºêÀÇ ³»±¸¼º Çâ»óÀ¸·Î ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °í·ÉÈ­ Àα¸ Áõ°¡¿Í ´ëµ¿¸ÆÆÇ¸· ÇùÂøÁõÀÇ ³ôÀº À¯º´·üÀº TAVR ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ :

TAVR ½ÃÀåÀº À¯¸ÁÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖÁö¸¸, ¸î °¡Áö µµÀü°úÁ¦·Î ÀÎÇØ ÀáÀç·ÂÀ» ÃæºÐÈ÷ ¹ßÈÖÇÏÁö ¸øÇϰí ÀÖÀ¸¸ç, ƯÈ÷ ½ÅÈï ½ÃÀåÀÇ º¹ÀâÇÑ ±ÔÁ¦ »óȲ°ú ÇÔ²² TAVR Àåºñ ¹× ½Ã¼úÀÇ ³ôÀº ºñ¿ëÀÌ Å« À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ °íµµ·Î Àü¹®È­µÈ ½Ã¼úÀ» ÇÒ ¼ö ÀÖ´Â ¼÷·ÃµÈ Àü¹®°¡°¡ ƯÁ¤ Áö¿ª¿¡ ºÎÁ·ÇÏ´Ù´Â Á¡µµ ±¤¹üÀ§ÇÑ ½ÃÀå¿¡¼­ÀÇ Ã¤ÅÃÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù. ÀúÀ§Çè ȯÀÚ¿¡¼­ ¹ëºêÀÇ Àå±â ³»±¸¼º¿¡ ´ëÇÑ ¿ì·Áµµ ½ÃÀå È®´ë¿¡ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ :

TAVR ½ÃÀåÀº ƯÈ÷ ÀÇ·á Çö´ëÈ­°¡ ÁøÇàµÇ°í ÀÖ´Â ½ÅÈï ½ÃÀå¿¡¼­ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç°ú °°Àº Áö¿ª¿¡¼­´Â ÀÇ·áºñ Áõ°¡¿Í ÷´Ü Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼º Çâ»óÀ¸·Î ÀÎÇØ ½ÃÀå ÁøÃâ±â¾÷¿¡°Ô À¯¸®ÇÑ ±âȸ°¡ âÃâµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àúħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í °í·ÉÃþ¿¡¼­ ºñ¼ö¼úÀû Ä¡·á¹ý¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ TAVR ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

  • ¼¼°è TAVR ½ÃÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
  • ´Ù¾çÇÑ ÇコÄɾî ȯ°æ¿¡¼­ ½ÃÀåÀº ¾î¶»°Ô ¼ºÀåÇϰí Àִ°¡?
  • TAVR ½Ã¼úÀÇ ¹Ì·¡¸¦ Çü¼ºÇϰí ÀÖ´Â ±â¼ú Çõ½ÅÀº ¹«¾ùÀΰ¡?
  • ½ÃÀå °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
  • ¼¼°è TAVR ½ÃÀå¿¡¼­ÀÇ »õ·Î¿î µ¿ÇâÀº?

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ
  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
    • ÁÖ¿ä µ¿Çâ
  • °æÄ«Å×ÅÍ ´ëµ¿¸ÆÆÇ ġȯÀÇ Ã¤ÅÃ/»ç¿ë »óȲ ºÐ¼® : Áö¿ªº°
  • PESTLE ºÐ¼®
  • Áö¿ªº° ÁÖ¿ä ±ÔÁ¦
  • Porter¡¯s Five Forces ºÐ¼®
  • °Å½Ã°æÁ¦ ¿äÀÎ
    • ¼¼°èÀÇ ºÎ¹®º° Àü¸Á
    • ¼¼°èÀÇ GDP ¼ºÀå Àü¸Á
    • ¼¼°èÀÇ ¸ð½ÃÀå °³¿ä

Á¦3Àå °¡°Ý µ¿Ç⠺м®, 2019-2023³â

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ½Ã¼ú ¿ä±Ý¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
  • ½Ã¼úº° ¿ä±Ý
  • Áö¿ªº° °¡°Ý°ú ÀýÂ÷

Á¦4Àå ¼¼°èÀÇ °æÄ«Å×ÅÍ ´ëµ¿¸ÆÆÇ ġȯ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
    • ½ÃÀå ±Ý¾×(10¾ï ´Þ·¯) ¿¹Ãø
    • ½ÃÀå ±Ô¸ð¿Í Àü³â´ëºñ ¼ºÀå·ü
    • Àý´ëÀû ¸ÅÃâ ±âȸ
  • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®, 2019-2023³â
    • ÇöÀç ½ÃÀå ±Ô¸ð ¿¹Ãø, 2023-2031³â
  • ¼¼°èÀÇ °æÄ«Å×ÅÍ ´ëµ¿¸ÆÆÇ ġȯ ½ÃÀå Àü¸Á : ½Ã¼ú
    • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
    • ½ÃÀå ±Ô¸ð(±Ý¾× ¹× ¼ö·®) ºÐ¼®, 2019-2023³â
    • ½ÃÀå ±Ô¸ð(±Ý¾× ¹× ¼ö·®) ¿¹Ãø, 2024-2031³â
      • °æ´ëÅð ÀÓÇöõÆ®
      • °æ±Ù÷ ÀÓÇöõÆ®
      • °æ´ëµ¿¸Æ ÀÓÇöõÆ®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ½Ã¼ú
  • ¼¼°èÀÇ °æÄ«Å×ÅÍ ´ëµ¿¸ÆÆÇ ġȯ ½ÃÀå Àü¸Á : ¸ÞÄ¿´ÏÁò
    • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
    • ½ÃÀå ±Ô¸ð(±Ý¾×) ºÐ¼®, 2019-2023³â
    • ½ÃÀå ±Ô¸ð(±Ý¾×) ¿¹Ãø, 2024-2031³â
      • ÀÚ±â È®Àå
      • dz¼± È®Àå °¡´É
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ¸ÞÄ¿´ÏÁò
  • ¼¼°èÀÇ °æÄ«Å×ÅÍ ´ëµ¿¸ÆÆÇ ġȯ ½ÃÀå Àü¸Á : ÃÖÁ¾ ¿ëµµ
    • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
    • ½ÃÀå ±Ô¸ð(±Ý¾×) ºÐ¼®, 2019-2023³â
    • ½ÃÀå ±Ô¸ð(±Ý¾×) ¿¹Ãø, 2024-2031³â
      • º´¿ø
      • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
      • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾ ¿ëµµ

Á¦5Àå ¼¼°èÀÇ °æÄ«Å×ÅÍ ´ëµ¿¸ÆÆÇ ġȯ ½ÃÀå Àü¸Á : Áö¿ª

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ½ÃÀå ±Ô¸ð(±Ý¾×) ºÐ¼®, 2019-2023³â
  • ½ÃÀå ±Ô¸ð(±Ý¾×) ¿¹Ãø, 2024-2031³â
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áö¿ª

Á¦6Àå ºÏ¹Ì°æÄ«Å×ÅÍ ´ëµ¿¸ÆÆÇ ġȯ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦7Àå À¯·´°æÄ«Å×ÅÍ ´ëµ¿¸ÆÆÇ ġȯ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °æÄ«Å×ÅÍ ´ëµ¿¸ÆÆÇ ġȯ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦9Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ °æÄ«Å×ÅÍ ´ëµ¿¸ÆÆÇ ġȯ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °æÄ«Å×ÅÍ ´ëµ¿¸ÆÆÇ ġȯ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • ½ÃÀå ±¸Á¶
    • ½ÃÀ庰 °æÀï °ÝÈ­ ¸Ê
    • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ °³¿ä(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
    • Boston Scientific Corporation
    • Medtronic Plc
    • Abbott Laboratories
    • Anteris Technologies Ltd.
    • Coroneo Inc.
    • CryoLife Inc.
    • Edward Lifesciences Corporation
    • JenaValve Technology Inc.
    • LifeNet Health Inc.
    • LivaNova PLC
    • Thubrikar Aortic Valve Inc.

Á¦12Àå ºÎ·Ï

  • Á¶»ç ¹æ¹ý
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
  • µÎÀÚ¾î¿Í ¾à¾î
KSA 24.10.15

Persistence Market Research has recently published a comprehensive report on the global Transcatheter Aortic Valve Replacement (TAVR) Market, offering an in-depth analysis of key market dynamics such as drivers, opportunities, challenges, and trends. The report provides valuable insights into the structure and future prospects of the market.

Key Insights:

  • Transcatheter Aortic Valve Replacement Market Size (2024E): USD 5.64 Bn
  • Projected Market Value (2031F): USD 10.5 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 6.5%

Transcatheter Aortic Valve Replacement Market - Report Scope:

The TAVR market focuses on the transcatheter-based procedure for replacing damaged aortic valves, particularly for patients who are at high or intermediate risk during traditional open-heart surgeries. This market is expanding rapidly due to advancements in valve technology and minimally invasive techniques. The increased adoption of TAVR procedures is being witnessed in hospitals, specialized cardiac centers, and clinics worldwide, driven by the aging population and the rising prevalence of cardiovascular diseases.

Market Growth Drivers:

The global TAVR market is primarily driven by the expanding indications for TAVR procedures, particularly for low-risk patients. The development of flexible and advanced delivery systems has enabled smoother and safer implantation procedures. Continuous innovation in valve materials and enhancements in valve durability are further supporting market growth. Additionally, the increasing aging population and the high prevalence of aortic stenosis contribute to the growing demand for TAVR procedures.

Market Restraints:

While the TAVR market shows promising growth, several challenges impede its full potential. High costs of TAVR devices and procedures, coupled with the complex regulatory landscape, particularly in emerging markets, present significant barriers. Additionally, a lack of skilled professionals in certain regions to perform these highly specialized procedures limits broader market adoption. Concerns over long-term valve durability in low-risk patients also pose challenges to market expansion.

Market Opportunities:

The TAVR market offers significant growth opportunities, especially in emerging markets with ongoing healthcare modernization efforts. Increasing healthcare expenditure and improving access to advanced treatments in regions like Asia-Pacific are creating lucrative opportunities for market players. Additionally, growing awareness of minimally invasive treatments and the rising preference for non-surgical options among the elderly population are boosting demand for TAVR procedures.

Key Questions Answered in the Report:

  • What are the key factors driving the TAVR market globally?
  • How is the market expanding in different healthcare settings?
  • Which technological innovations are shaping the future of TAVR procedures?
  • Who are the leading players in the market, and what strategies are they adopting to stay competitive?
  • What are the emerging trends in the global TAVR market?

Competitive Intelligence and Business Strategy:

Leading players in the global TAVR market are investing in research and development (R&D) to innovate advanced valve systems and delivery platforms. Companies are focusing on strategic partnerships with hospitals and specialized cardiac centers to increase the adoption of TAVR procedures. Significant emphasis is placed on consumer education and regulatory approvals, which play a critical role in the competitive landscape.

Key Market Players

  • Boston Scientific Corporation
  • Medtronic Plc
  • Abbott Laboratories
  • Anteris Technologies Ltd.
  • Coroneo Inc.
  • CryoLife Inc.
  • Edward Lifesciences Corporation
  • JenaValve Technology Inc.
  • LifeNet Health Inc.
  • LivaNova PLC
  • Thubrikar Aortic Valve Inc.

Transcatheter Aortic Valve Replacement Market Segmentation

By Procedure

  • Transfemoral Implantation
  • Transapical Implantation
  • Transaortic Implantation

By Mechanism

  • Self-Expanding
  • Balloon-expandable

By End User

  • Hospital
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Transcatheter Aortic Valve Replacement Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Transcatheter Aortic Valve Replacement Adoption / Usage Analysis, By Region
  • 2.4. PESTLE Analysis
  • 2.5. Key Regulations by Region
  • 2.6. Porter Five Force's Analysis
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview

3. Price Trend Analysis, 2019-2031

  • 3.1. Key Highlights
  • 3.2. Key Factors Impacting Procedure Prices
  • 3.3. Prices By Procedure
  • 3.4. Regional Prices and Procedure Preferences

4. Global Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 4.1. Key Highlights
    • 4.1.1. Market Value (US$ in Bn) Projections
    • 4.1.2. Market Size and Y-o-Y Growth
    • 4.1.3. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size Analysis, 2019-2023
    • 4.2.2. Current Market Size Forecast, 2023-2031
  • 4.3. Global Transcatheter Aortic Valve Replacement Market Outlook: Procedure
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) and Volume (Units) and Analysis by Procedure, 2019-2023
    • 4.3.3. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
      • 4.3.3.1. Transfemoral Implantation
      • 4.3.3.2. Transapical Implantation
      • 4.3.3.3. Transaortic Implantation
  • 4.4. Market Attractiveness Analysis: Procedure
  • 4.5. Global Transcatheter Aortic Valve Replacement Market Outlook: Mechanism
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis by Mechanism, 2019-2023
    • 4.5.3. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
      • 4.5.3.1. Self-Expanding
      • 4.5.3.2. Balloon-Expandable
  • 4.6. Market Attractiveness Analysis: Mechanism
  • 4.7. Global Transcatheter Aortic Valve Replacement Market Outlook: End-use
    • 4.7.1. Introduction / Key Findings
    • 4.7.2. Historical Market Size (US$ Bn) Analysis by End-use, 2019-2023
    • 4.7.3. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
      • 4.7.3.1. Hospital
      • 4.7.3.2. Ambulatory Surgical Centers
      • 4.7.3.3. Others
  • 4.8. Market Attractiveness Analysis: End-use

5. Global Transcatheter Aortic Valve Replacement Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis by Region, 2019-2023
  • 5.3. Current Market Size (US$ Bn) Forecast by Region, 2024-2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
    • 6.2.1. By Country
    • 6.2.2. By Procedure
    • 6.2.3. By Mechanism
    • 6.2.4. By End-use
  • 6.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
    • 6.4.1. Transfemoral Implantation
    • 6.4.2. Transapical Implantation
    • 6.4.3. Transaortic Implantation
  • 6.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
    • 6.5.1. Self-Expanding
    • 6.5.2. Balloon-expandable
  • 6.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
    • 6.6.1. Hospital
    • 6.6.2. Ambulatory Surgical Centers
    • 6.6.3. Dental Clinics
  • 6.7. Market Attractiveness Analysis

7. Europe Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
    • 7.2.1. By Country
    • 7.2.2. By Procedure
    • 7.2.3. By Mechanism
    • 7.2.4. By End-use
  • 7.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
    • 7.3.1. Germany
    • 7.3.2. Italy
    • 7.3.3. France
    • 7.3.4. U.K.
    • 7.3.5. Turkey
    • 7.3.6. Russia
    • 7.3.7. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
    • 7.4.1. Transfemoral Implantation
    • 7.4.2. Transapical Implantation
    • 7.4.3. Transaortic Implantation
  • 7.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
    • 7.5.1. Self-Expanding
    • 7.5.2. Balloon-expandable
  • 7.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
    • 7.6.1. Hospital
    • 7.6.2. Ambulatory Surgical Centers
    • 7.6.3. Dental Clinics
  • 7.7. Market Attractiveness Analysis

8. Asia Pacific Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
    • 8.2.1. By Country
    • 8.2.2. By Procedure
    • 8.2.3. By Mechanism
    • 8.2.4. By End-use
  • 8.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
    • 8.3.4. India
    • 8.3.5. Southeast Asia
    • 8.3.6. Rest of Asia Pacific
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
    • 8.4.1. Transfemoral Implantation
    • 8.4.2. Transapical Implantation
    • 8.4.3. Transaortic Implantation
  • 8.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
    • 8.5.1. Self-Expanding
    • 8.5.2. Balloon-expandable
  • 8.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
    • 8.6.1. Hospital
    • 8.6.2. Ambulatory Surgical Centers
    • 8.6.3. Dental Clinics
  • 8.7. Market Attractiveness Analysis

9. Latin America Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
    • 9.2.1. By Country
    • 9.2.2. By Procedure
    • 9.2.3. By Mechanism
    • 9.2.4. By End-use
  • 9.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Argentina
    • 9.3.4. Rest of Latin America
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
    • 9.4.1. Transfemoral Implantation
    • 9.4.2. Transapical Implantation
    • 9.4.3. Transaortic Implantation
  • 9.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
    • 9.5.1. Self-Expanding
    • 9.5.2. Balloon-expandable
  • 9.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
    • 9.6.1. Hospital
    • 9.6.2. Ambulatory Surgical Centers
    • 9.6.3. Dental Clinics
  • 9.7. Market Attractiveness Analysis

10. Middle East & Africa Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
    • 10.2.1. By Country
    • 10.2.2. By Procedure
    • 10.2.3. By Mechanism
    • 10.2.4. By End-use
  • 10.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
    • 10.3.1. GCC Countries
    • 10.3.2. South Africa
    • 10.3.3. Egypt
    • 10.3.4. Nigeria
    • 10.3.5. Rest of Middle East and Africa
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
    • 10.4.1. Transfemoral Implantation
    • 10.4.2. Transapical Implantation
    • 10.4.3. Transaortic Implantation
  • 10.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
    • 10.5.1. Self-Expanding
    • 10.5.2. Balloon-expandable
  • 10.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
    • 10.6.1. Hospital
    • 10.6.2. Ambulatory Surgical Centers
    • 10.6.3. Dental Clinics
  • 10.7. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping by Market
    • 11.2.2. Competition Dashboard
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Boston Scientific Corporation
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Medtronic Plc
    • 11.3.3. Abbott Laboratories
    • 11.3.4. Anteris Technologies Ltd.
    • 11.3.5. Coroneo Inc.
    • 11.3.6. CryoLife Inc.
    • 11.3.7. Edward Lifesciences Corporation
    • 11.3.8. JenaValve Technology Inc.
    • 11.3.9. LifeNet Health Inc.
    • 11.3.10. LivaNova PLC
    • 11.3.11. Thubrikar Aortic Valve Inc.

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦